Results 221 to 230 of about 53,339 (246)
Some of the next articles are maybe not open access.
Journal of Evaluation in Clinical Practice, 2020
RATIONALE, AIMS, AND OBJECTIVES As a pharmacovigilance measure, the Brazilian Health Regulatory Agency (ANVISA) monitors the postmarketing events of medication and issues alerts on actions to be taken and information updates.
Vitor Costa Ferreira +2 more
exaly +5 more sources
RATIONALE, AIMS, AND OBJECTIVES As a pharmacovigilance measure, the Brazilian Health Regulatory Agency (ANVISA) monitors the postmarketing events of medication and issues alerts on actions to be taken and information updates.
Vitor Costa Ferreira +2 more
exaly +5 more sources
Revista Digital De Direito Administrativo
The article aims to develop a critical and historical analysis of the prior consent of patents for pharmaceutical products and processes by the Brazilian Health Regulatory Agency (Anvisa) from its creation until its extinction.
Allan Fuezi Barbosa +2 more
exaly +2 more sources
The article aims to develop a critical and historical analysis of the prior consent of patents for pharmaceutical products and processes by the Brazilian Health Regulatory Agency (Anvisa) from its creation until its extinction.
Allan Fuezi Barbosa +2 more
exaly +2 more sources
Revista Eletrônica de Gestão e Tecnologias Ambientais, 2020 Os residuos de servicos de saude (RSS) sao reconhecidos por sua periculosidade e consequencias associadas ao manejo inadequado, necessitando, assim, de regulamentacao e controle.
Adílio Campos Portugal, L. R. Moraes
semanticscholar +3 more sources
Vitamin Dietary Supplement: Changes and Challenges with the New ANVISA Regulations [PDF]
International Journal of Nutrology, 2021 AbstractIn July 2018, the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária, ANVISA, in Portuguese) published new regulations for food supplements, leading to changes both in the sales denomination and labeling statements, and in the composition of these products.
Lucile Tiemi Abe-matsumoto
exaly +3 more sources
Revista de informacao legislativa, 2021
Este artigo tem por objetivo analisar a produção normativa da Anvisa em resposta à crise de saúde pública gerada pelo novo coronavírus. Com base em levantamento das medidas regulatórias adotadas pela Agência entre os meses de janeiro a junho de 2020 ...
Natasha Schmitt Caccia Salinas +2 more
semanticscholar +1 more source
Este artigo tem por objetivo analisar a produção normativa da Anvisa em resposta à crise de saúde pública gerada pelo novo coronavírus. Com base em levantamento das medidas regulatórias adotadas pela Agência entre os meses de janeiro a junho de 2020 ...
Natasha Schmitt Caccia Salinas +2 more
semanticscholar +1 more source
Global Public Health, 2018 Evidence is an important resource for policy makers. Alongside its practical utility, evidence is a persuasive strategic and rhetorical tool. This study scrutinises the information used by tobacco interests in opposition to Brazil's National Health Surveillance Agency's (ANVISA) 2012 regulations.
R. Lencucha, Clelio de Lima Pontes
semanticscholar +3 more sources
Should ANVISA be permitted to reject pharmaceutical patent applications in Brazil?
Expert Opinion on Therapeutic Patents, 2014Pharmaceutical manufacturers who seek new markets for expansion are particularly attracted to Brazil given its potential for growth and the expectation that it will be the fifth largest drug market by 2015. Given the significance of Brazil in the marketplace, strong patent protection for pharmaceutical products and processes is critical. In April 2013,
Lisa Mueller +1 more
semanticscholar +4 more sources